{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:16:21Z","timestamp":1794244581153,"version":"4.9.0"},"reference-count":177,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.eclinm.2024.102507","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T19:41:21Z","timestamp":1710358881000},"page":"102507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4571-1079","authenticated-orcid":false,"given":"Jaden","family":"Brandt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolene","family":"Bressi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00ea-Linh","family":"L\u00ea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejanee","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathal","family":"Cadogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Witt-Doerring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Witt-Doerring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.eclinm.2024.102507_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000524400","article-title":"Benzodiazepines remain important therapeutic options in psychiatric practice","volume":"91","author":"Dubovsky","year":"2022","journal-title":"Psychother Psychosom"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102507_bib2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.janxdis.2011.01.002","article-title":"The discovery of chlordiazepoxide and the clinical introduction of benzodiazepines: half a century of anxiolytic drugs","volume":"25","author":"L\u00f3pez-Mu\u00f1oz","year":"2011","journal-title":"J\u00a0Anxiety Disord"},{"key":"10.1016\/j.eclinm.2024.102507_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1054-3589(08)60658-4","article-title":"Pharmacology of benzodiazepines: laboratory and clinical correlations","volume":"5","author":"Zbinden","year":"1967","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.eclinm.2024.102507_bib4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF00504702","article-title":"The effect of diazepam on spinal cord activities: possible sites and mechanisms of action","volume":"284","author":"Polc","year":"1974","journal-title":"N\u00a0Schmied Arch Pharmacol"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102507_bib5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.tips.2018.03.006","article-title":"The benzodiazepine binding sites of GABAA receptors","volume":"39","author":"Sigel","year":"2018","journal-title":"Trends Pharmacol Sci"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102507_bib6","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4140\/TCP.n.2013.538","article-title":"The history of benzodiazepines","volume":"28","author":"Wick","year":"2013","journal-title":"Consult Pharm"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102507_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.yco.0000165594.60434.84","article-title":"The diagnosis and management of benzodiazepine dependence","volume":"18","author":"Ashton","year":"2005","journal-title":"Curr Opin Psychiatry"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102507_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2125.2012.04418.x","article-title":"Benzodiazepine harm: how can it be reduced?","volume":"77","author":"Lader","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102507_bib9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40268-017-0207-7","article-title":"Benzodiazepines and Z-drugs: an updated review of major adverse outcomes reported on in epidemiologic research","volume":"17","author":"Brandt","year":"2017","journal-title":"Drugs R D"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102507_bib10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jamapsychiatry.2022.1150","article-title":"Complex persistent benzodiazepine dependence\u2013when benzodiazepine deprescribing goes awry","volume":"79","author":"Peng","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102507_bib11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/gps.5048","article-title":"Benzodiazepines or related drugs and risk of pneumonia: a systematic review and meta-analysis","volume":"34","author":"Sun","year":"2019","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102507_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s41999-021-00553-w","article-title":"Is there a link between the use of benzodiazepines and related drugs and dementia? A systematic review of reviews","volume":"13","author":"Ferreira","year":"2022","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.eclinm.2024.102507_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/00912174231166252","article-title":"Chronic use of benzodiazepines: the problem that persists","author":"Louie","year":"2023","journal-title":"Int J Psychiatr Med"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102507_bib14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMp1715050","article-title":"Our other prescription drug problem","volume":"378","author":"Lembke","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2024.102507_bib15","doi-asserted-by":"crossref","DOI":"10.1177\/20451253221145561","article-title":"Enduring neurological sequelae of benzodiazepine use: an Internet survey","volume":"13","author":"Huff","year":"2023","journal-title":"Ther Adv Psychopharmacol"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102507_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0285584","article-title":"Long-term consequences of benzodiazepine-induced neurological dysfunction: a survey","volume":"18","author":"Ritvo","year":"2023","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102507_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000525207","article-title":"Who's afraid of benzodiazepines?","volume":"91","author":"Balon","year":"2022","journal-title":"Psychother Psychosom"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102507_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1192\/bja.2022.62","article-title":"The devil is in the detail: a critique of nine editorials published by the International Task Force on Benzodiazepines","volume":"30","author":"Brandt","year":"2024","journal-title":"BJPsych Adv"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102507_bib19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1177\/070674371005501104","article-title":"Are there guidelines for the responsible prescription of benzodiazepines?","volume":"55","author":"el-Guebaly","year":"2010","journal-title":"Can J Psychiatr"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102507_bib20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000524772","article-title":"Representation of benzodiazepines in treatment guidelines: the paradox of undesirable objectivity","volume":"91","author":"Starcevic","year":"2022","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.eclinm.2024.102507_bib21","series-title":"Comorbid anxiety and depression: clinical and conceptual consideration and transdiagnostic treatment in Anxiety disorders: Rethinking and understanding recent discoveries","first-page":"219","author":"Choi","year":"2020"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102507_bib22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102507_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol"},{"key":"10.1016\/j.eclinm.2024.102507_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12874-016-0116-4","article-title":"A\u00a0scoping review on the conduct and reporting of scoping reviews","volume":"16","author":"Tricco","year":"2016","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102507_bib25","first-page":"124","article-title":"Covidence and rayyan","volume":"37","author":"Couban","year":"2016","journal-title":"J\u00a0Can Health Libr Assoc"},{"key":"10.1016\/j.eclinm.2024.102507_bib26","article-title":"BZRA recommendations from guidelines and guidance documents: scoping review","author":"Brandt","year":"2021","journal-title":"Open Sci Framework"},{"key":"10.1016\/j.eclinm.2024.102507_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.eclinm.2024.102507_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS peer review of electronic search strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.eclinm.2024.102507_bib29","series-title":"SearchFilter: guidelines\u2013standard\u2013PubMed. CADTH search filters database","author":"Canadian Agency for Drugs and Technology in Health","year":"2023"},{"key":"10.1016\/j.eclinm.2024.102507_bib30","series-title":"Gray matters: a practical tool for searching health-related grey literature","first-page":"1","author":"Canadian Agency for Drugs and Technologies in Health","year":"2019"},{"key":"10.1016\/j.eclinm.2024.102507_bib31","series-title":"Clinical practice guidelines we can trust","author":"Steinberg","year":"2011"},{"issue":"16","key":"10.1016\/j.eclinm.2024.102507_bib32","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.3390\/ijerph20166565","article-title":"Consensus panel recommendations for the pharmacological management of\u00a0pregnant women with depressive disorders","volume":"20","author":"Eleftheriou","year":"2023","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.eclinm.2024.102507_bib33","first-page":"1","article-title":"Recommendations for treatment of unipolar depressive disorder","author":"Ilje\u0161","year":"2023","journal-title":"Slov Med J"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102507_bib34","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1097\/AOG.0000000000005202","article-title":"Treatment and management of mental health conditions during pregnancy and postpartum: ACOG clinical practice guideline No. 5","volume":"141","author":"Miller","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102507_bib35","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/epi.17140","article-title":"ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy","volume":"63","author":"Mula","year":"2022","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102507_bib36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.15557\/PiPK.2018.0029","article-title":"Evidence-Based practice guideline for the treatment of adult patients with depressive disorders. Part I: psychiatric management","volume":"18","author":"Voytenko","year":"2018","journal-title":"Psychiatr i Psychol Klin"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102507_bib37","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5114\/fmpcr.2017.69300","article-title":"Guidelines of the polish psychiatric association\u2013wroclaw division, the polish society of family medicine and the college of family physicians in Poland for diagnosis and treatment of depressive disorders in primary health care","author":"Piotrowski","year":"2017","journal-title":"Fam Med Prim Care Rev"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102507_bib38","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0706743716659417","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments","volume":"61","author":"Kennedy","year":"2016","journal-title":"Can J Psychiatr"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102507_bib39","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/15622975.2013.804195","volume":"14","author":"Bauer","year":"2013","journal-title":"World J Biol Psychiatr"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102507_bib40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/15622975.2014.1001786","volume":"16","author":"Bauer","year":"2015","journal-title":"World J Biol Psychiatr"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102507_bib41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.wombi.2011.12.001","article-title":"Detection and management of mood disorders in the maternity setting: the Australian Clinical Practice Guidelines","volume":"26","author":"Austin","year":"2013","journal-title":"Women Birth"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102507_bib42","first-page":"137","article-title":"Ministry of Health clinical practice guidelines: depression","volume":"53","author":"Chua","year":"2012","journal-title":"Singap Med J"},{"key":"10.1016\/j.eclinm.2024.102507_bib43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0447.2009.01382.x","article-title":"Clinical practice recommendations for depression","volume":"119","author":"Malhi","year":"2009","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.eclinm.2024.102507_bib44","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1590\/S1516-44462009000500003","article-title":"Review of the guidelines of the Brazilian Medical Association for the treatment of depression (Full version)","volume":"31","author":"Fleck","year":"2009","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102507_bib45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/026988110001400101","article-title":"Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines","volume":"14","author":"Anderson","year":"2000","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.eclinm.2024.102507_bib46","series-title":"National guidelines for seniors' mental health: the assessment and treatment of mental health issues in long-term care homes (focus on mood and behaviour symptoms)","first-page":"1","author":"Conn","year":"2006"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102507_bib47","first-page":"56","article-title":"The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid personality disorders","volume":"24","author":"Rosenbluth","year":"2012","journal-title":"Ann Clin Psychiatr"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102507_bib48","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3109\/00048674.2011.595686","article-title":"A\u00a0consensus statement for safety monitoring guidelines of treatments for major depressive disorder","volume":"45","author":"Dodd","year":"2011","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102507_bib49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/13651500701330791","article-title":"Revised psychopharmacological algorithms for the treatment of mood disorders in Japan","volume":"12","author":"Motohashi","year":"2008","journal-title":"Int J Psychiatr Clin Pract"},{"key":"10.1016\/j.eclinm.2024.102507_bib50","first-page":"523","article-title":"[Summary of the standard \u2018depressive disorder' (first revision) of the Dutch society of general practitioners]","volume":"149","author":"Romeijnders","year":"2005","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102507_bib51","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4088\/JCP.v60n0302","article-title":"The Texas medication algorithm project: report of the Texas consensus conference panel on medication treatment of major depressive disorder","volume":"60","author":"Crismon","year":"1999","journal-title":"J\u00a0Clin Psychiatr"},{"key":"10.1016\/j.eclinm.2024.102507_bib52","series-title":"Major depressive disorder in adults: diagnosis & management","first-page":"1","year":"2013"},{"key":"10.1016\/j.eclinm.2024.102507_bib53","series-title":"Management of major depressive disorder","first-page":"1","year":"2019"},{"key":"10.1016\/j.eclinm.2024.102507_bib54","series-title":"Institute for clinical system improvement. Adult depression in primary care: healthcare guideline","first-page":"1","author":"Trangle","year":"2016"},{"key":"10.1016\/j.eclinm.2024.102507_bib55","series-title":"Sign 127: management of perinatal mood disorders","first-page":"1","year":"2012"},{"key":"10.1016\/j.eclinm.2024.102507_bib56","series-title":"[NHG-Standaard depressie (M44)]","first-page":"1","author":"Claassen","year":"2022"},{"key":"10.1016\/j.eclinm.2024.102507_bib57","series-title":"Depression: good medical practice","year":"2023"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102507_bib58","first-page":"6","article-title":"The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders","volume":"24","author":"Schaffer","year":"2012","journal-title":"Ann Clin Psychiatr"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102507_bib59","first-page":"389","article-title":"Guidelines for the treatment of depression","volume":"55","author":"Fuchs","year":"2000","journal-title":"Rev Med Liege"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102507_bib60","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1177\/0004867418799453","article-title":"Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder","volume":"52","author":"Andrews","year":"2018","journal-title":"Aust N Z J Psychiatr"},{"issue":"Suppl 3","key":"10.1016\/j.eclinm.2024.102507_bib61","doi-asserted-by":"crossref","first-page":"S371","DOI":"10.4103\/0019-5545.224476","article-title":"Clinical practice guidelines for geriatric anxiety disorders","volume":"60","author":"Subramanyam","year":"2018","journal-title":"Indian J Psychiatr"},{"issue":"Suppl 1","key":"10.1016\/j.eclinm.2024.102507_bib62","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.4103\/0019-5545.196975","article-title":"Clinical practice guidelines for the management of generalised anxiety disorder (GAD) and panic disorder (PD)","volume":"59","author":"Gautam","year":"2017","journal-title":"Indian J Psychiatr"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102507_bib63","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00406-021-01324-1","article-title":"The German Guidelines for the treatment of anxiety disorders: first revision","volume":"272","author":"Bandelow","year":"2022","journal-title":"Eur Arch Psychiatr Clin Neurosci"},{"key":"10.1016\/j.eclinm.2024.102507_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-244X-14-S1-S1","article-title":"Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders","volume":"14","author":"Katzman","year":"2014","journal-title":"BMC Psychiatry"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102507_bib65","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0269881114525674","article-title":"Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology","volume":"28","author":"Baldwin","year":"2014","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.eclinm.2024.102507_bib66","series-title":"Generalised anxiety disorder and panic disorder in adults: management","first-page":"1","year":"2011"},{"key":"10.1016\/j.eclinm.2024.102507_bib67","series-title":"Guideline working group for the treatment of patients with anxiety disorders in primary care","year":"2008"},{"key":"10.1016\/j.eclinm.2024.102507_bib68","series-title":"Magellan's clinical practice guideline for the assessment and treatment of generalized anxiety disorder in adults","first-page":"1","author":"Heggie","year":"2018"},{"key":"10.1016\/j.eclinm.2024.102507_bib69","series-title":"Anxiety disorders. Current care guidelines","year":"2019"},{"key":"10.1016\/j.eclinm.2024.102507_bib70","series-title":"[NHG-Standard anxiety (M62)]","first-page":"1","year":"2019"},{"key":"10.1016\/j.eclinm.2024.102507_bib71","series-title":"[Acts and services for long-term conditions: serious anxiety disorders]","author":"Haute Autorit\u00e9 de Sant\u00e9","year":"2017"},{"key":"10.1016\/j.eclinm.2024.102507_bib72","series-title":"Dartmouth-hitchcock. Clinical practice guideline: management of anxiety in adults in primary care","first-page":"1","author":"Brackett","year":"2019"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102507_bib73","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/13651501.2012.722645","article-title":"The best next drug in the course of generalized anxiety disorders: the \u201cPN-GAD-algorithm\u201d","volume":"17","author":"Linden","year":"2013","journal-title":"Int J Psychiatr Clin Pract"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102507_bib74","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/HRP.0000000000000098","article-title":"The psychopharmacology algorithm project at the Harvard South Shore Program: an algorithm for generalized anxiety disorder","volume":"24","author":"Abejuela","year":"2016","journal-title":"Harv Rev Psychiatr"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102507_bib75","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0269881108096505","article-title":"A\u00a0psychopharmacological treatment algorithm for generalised anxiety disorder (GAD)","volume":"24","author":"Davidson","year":"2010","journal-title":"J\u00a0Psychopharmacol"},{"issue":"S1","key":"10.1016\/j.eclinm.2024.102507_bib76","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1017\/S1092852900006945","article-title":"WCA recommendations for the long-term treatment of generalized anxiety disorder","volume":"8","author":"Allgulander","year":"2003","journal-title":"CNS Spectr"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102507_bib77","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/15622975.2022.2086295","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders\u2013Version 3. Part I: anxiety disorders","volume":"24","author":"Bandelow","year":"2023","journal-title":"World J Biol Psychiatr"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102507_bib78","doi-asserted-by":"crossref","first-page":"147","DOI":"10.30773\/pi.2017.05.01","article-title":"Korean guidelines for the pharmacological treatment of social anxiety disorder: initial treatment strategies","volume":"15","author":"Yoon","year":"2018","journal-title":"Psychiatry Investig"},{"key":"10.1016\/j.eclinm.2024.102507_bib79","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1590\/S1516-44462011000300014","article-title":"Guidelines of the Brazilian Medical Association for the treatment of social anxiety disorder","volume":"33","author":"Levitan","year":"2011","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.eclinm.2024.102507_bib80","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11920-010-0140-8","article-title":"A\u00a02010 evidence-based algorithm for the pharmacotherapy of social anxiety disorder","volume":"12","author":"Stein","year":"2010","journal-title":"Curr Psychiatr Rep"},{"issue":"S1","key":"10.1016\/j.eclinm.2024.102507_bib81","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1017\/S1092852900006933","article-title":"WCA recommendations for the long-term treatment of social phobia","volume":"8","author":"Van Ameringen","year":"2003","journal-title":"CNS Spectr"},{"key":"10.1016\/j.eclinm.2024.102507_bib82","first-page":"54","article-title":"Consensus statement on social anxiety disorder from the international consensus group on depression and anxiety","volume":"59","author":"Ballenger","year":"1998","journal-title":"J\u00a0Clin Psychiatr"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102507_bib83","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1185\/135525701317094368","article-title":"Pharmacotherapy of social anxiety disorder: an algorithm for primary care\u20132001","volume":"7","author":"Stein","year":"2001","journal-title":"Prim Care Psychiatr"},{"key":"10.1016\/j.eclinm.2024.102507_bib84","series-title":"Social anxiety disorder: the NICE guideline on recognition, assessment and treatment","first-page":"1","year":"2013"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102507_bib85","first-page":"1","article-title":"Practice guideline for the treatment of patients with panic disorder (2nd ed.)","volume":"166","author":"Stein","year":"2009","journal-title":"Am Psychiatr Assoc"},{"issue":"S1","key":"10.1016\/j.eclinm.2024.102507_bib86","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1017\/S109285290000691X","article-title":"WCA recommendations for the long-term treatment of panic disorder","volume":"8","author":"Pollack","year":"2003","journal-title":"CNS Spectr"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102507_bib87","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3122\/jabfm.11.4.282","article-title":"Pharmacotherapy of panic disorder: proposed guidelines for the family physician","volume":"11","author":"Roy-Byrne","year":"1998","journal-title":"J\u00a0Am Board Fam Pract"},{"key":"10.1016\/j.eclinm.2024.102507_bib88","first-page":"47","article-title":"Consensus statement on panic disorder from the international consensus group on depression and anxiety","volume":"59","author":"Ballenger","year":"1998","journal-title":"J\u00a0Clin Psychiatr"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102507_bib89","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/15622975.2022.2086296","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders\u2013Version 3. Part II: OCD and PTSD","volume":"24","author":"Bandelow","year":"2023","journal-title":"World J Biol Psychiatr"},{"issue":"S1","key":"10.1016\/j.eclinm.2024.102507_bib90","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.4103\/0019-5545.196976","article-title":"Clinical practice guidelines for obsessive-compulsive disorder","volume":"59","author":"Reddy","year":"2017","journal-title":"Indian J Psychiatr"},{"key":"10.1016\/j.eclinm.2024.102507_bib91","first-page":"146","article-title":"Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part I: pharmacological treatment","volume":"45","author":"de Oliveira","year":"2023","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.eclinm.2024.102507_bib92","series-title":"Guideline watch (March 2013): practice guideline for the treatment of patients with obsessive-compulsive disorder","first-page":"1","author":"Koran","year":"2013"},{"issue":"S1","key":"10.1016\/j.eclinm.2024.102507_bib93","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S1092852900006908","article-title":"WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults","volume":"8","author":"Greist","year":"2003","journal-title":"CNS Spectr"},{"key":"10.1016\/j.eclinm.2024.102507_bib94","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11920-012-0268-9","article-title":"A\u00a02012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder","volume":"14","author":"Stein","year":"2012","journal-title":"Curr Psychiatr Rep"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102507_bib95","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/00048670701449161","article-title":"Australian guidelines for the treatment of adults with acute stress disorder and post-traumatic stress disorder","volume":"41","author":"Forbes","year":"2007","journal-title":"Aust N Z J Psychiatr"},{"key":"10.1016\/j.eclinm.2024.102507_bib96","series-title":"Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder","first-page":"1","author":"Ursano","year":"2010"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102507_bib97","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1023\/A:1007802031411","article-title":"Guidelines for treatment of PTSD","volume":"13","author":"Foa","year":"2000","journal-title":"J\u00a0Trauma Stress"},{"issue":"S1","key":"10.1016\/j.eclinm.2024.102507_bib98","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1017\/S1092852900006921","article-title":"WCA Recommendations for the long-term treatment of posttraumatic stress disorder","volume":"8","author":"Stein","year":"2003","journal-title":"CNS Spectr"},{"key":"10.1016\/j.eclinm.2024.102507_bib99","series-title":"Helping patients taper from benzodiazepines","first-page":"1","author":"National Center for PTSD","year":"2013"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102507_bib100","first-page":"1","article-title":"Alliance for sleep clinical practice guideline on switching or deprescribing hypnotic medications for insomnia","volume":"12","author":"Watson","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102507_bib101","doi-asserted-by":"crossref","DOI":"10.12740\/PP\/OnlineFirst\/161597","article-title":"Treatment of insomnia in older adults. Recommendations of the polish sleep research society, polish society of family medicine and the polish psychiatric association","volume":"57","author":"Wichniak","year":"2023","journal-title":"Psychiatr Pol"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102507_bib102","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/M19-3575","article-title":"The management of chronic insomnia disorder and obstructive sleep apnea: synopsis of the 2019 US Department of Veterans Affairs and US Department of Defense clinical practice guidelines","volume":"172","author":"Mysliwiec","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eclinm.2024.102507_bib103","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3389\/fpsyt.2020.00558","article-title":"Expert opinions and consensus recommendations for the evaluation and management of insomnia in clinical practice: joint statements of five Italian scientific societies","volume":"11","author":"Palagini","year":"2020","journal-title":"Front Psychiatr"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102507_bib104","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.30773\/pi.2020.0146","article-title":"Korean clinical practice guideline for the diagnosis and treatment of insomnia in adults","volume":"17","author":"Choi","year":"2020","journal-title":"Psychiatry Investig"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102507_bib105","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/0269881119855343","article-title":"British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update","volume":"33","author":"Wilson","year":"2019","journal-title":"J\u00a0Psychopharmacol"},{"issue":"S3","key":"10.1016\/j.eclinm.2024.102507_bib106","doi-asserted-by":"crossref","first-page":"S383","DOI":"10.4103\/0019-5545.224477","article-title":"Clinical practice guideline on management of sleep disorders in the elderly","volume":"60","author":"Praharaj","year":"2018","journal-title":"Indian J Psychiatr"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102507_bib107","first-page":"339","article-title":"Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline","volume":"64","author":"Pottie","year":"2018","journal-title":"Can Fam Physician"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102507_bib108","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5664\/jcsm.6470","article-title":"Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline","volume":"13","author":"Sateia","year":"2017","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102507_bib109","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/jsr.12594","article-title":"European guideline for the diagnosis and treatment of insomnia","volume":"26","author":"Riemann","year":"2017","journal-title":"J\u00a0Sleep Res"},{"issue":"S1","key":"10.1016\/j.eclinm.2024.102507_bib110","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.4103\/0019-5545.196978","article-title":"Clinical practice guidelines for sleep disorders","volume":"59","author":"Gupta","year":"2017","journal-title":"Indian J Psychiatr"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102507_bib111","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7326\/M15-2175","article-title":"Clinical Guidelines Committee of the American College of Physicians. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians","volume":"165","author":"Qaseem","year":"2016","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102507_bib112","first-page":"108","article-title":"Clinical practice guideline. Diagnosis and treatment of insomnia in the elderly","volume":"52","author":"Medina-Ch\u00e1vez","year":"2014","journal-title":"Rev M\u00e9d Inst Mex Seguro Soc"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102507_bib113","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1590\/S0004-282X2010000400038","article-title":"New guidelines for diagnosis and treatment of insomnia","volume":"68","author":"Pinto","year":"2010","journal-title":"Arq Neuropsiquiatr"},{"issue":"S1","key":"10.1016\/j.eclinm.2024.102507_bib114","first-page":"4","article-title":"[Non restorative sleep\u2044 sleep disorders. German Sleep Society]","volume":"13","author":"Mayer","year":"2009","journal-title":"Somnologie"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102507_bib115","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1532-5415.2009.02220.x","article-title":"Evidence-based recommendations for the assessment and management of sleep disorders in older persons","volume":"57","author":"Bloom","year":"2009","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.eclinm.2024.102507_bib116","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2165\/00044011-200525120-00002","article-title":"Insomnia in general practice: a consensus report produced by sleep specialists and primary-care physicians in Italy","volume":"25","author":"Terzano","year":"2005","journal-title":"Clin Drug Invest"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102507_bib117","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2165\/00044011-200323060-00001","article-title":"Consensus on drug treatment, definition and diagnosis for insomnia","volume":"23","author":"Estivill","year":"2003","journal-title":"Clin Drug Invest"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102507_bib118","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1742-1241.2001.tb10973.x","article-title":"Consensus for the pharmacological management of insomnia in the new millennium","volume":"55","author":"Roth","year":"2001","journal-title":"Int J Clin Pract"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102507_bib119","first-page":"5","article-title":"Hypnotics in the elderly: appropriate usage guidelines","volume":"6","author":"Yakabowich","year":"1992","journal-title":"J\u00a0Geriatr Drug Ther"},{"key":"10.1016\/j.eclinm.2024.102507_bib120","series-title":"Towards optimized practice: assessment to management of adult insomnia","first-page":"1","author":"Alberta Doctors","year":"2015"},{"key":"10.1016\/j.eclinm.2024.102507_bib121","first-page":"A8679","article-title":"[The NHG guideline \u2019Sleep problems and sleeping pills']","volume":"159","author":"Damen-van Beek","year":"2015","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.eclinm.2024.102507_bib122","series-title":"Insomnia. Valid treatment recommendation","year":"2023"},{"key":"10.1016\/j.eclinm.2024.102507_bib123","series-title":"First-line treatment of sleep disorders and insomnia in adults","first-page":"1","author":"Cloetens","year":"2018"},{"key":"10.1016\/j.eclinm.2024.102507_bib124","series-title":"BE-SAFE: deprescription of benzodiazepine and sedative hypnotics (BSHs) in insomnia disorder","author":"Agoritsas","year":"2023"},{"key":"10.1016\/j.eclinm.2024.102507_bib125","series-title":"Benzodiazepine action working group on behalf of Benzodiazepine Information Coalition and Alliance for Benzodiazepine Best Practices","year":"2022"},{"key":"10.1016\/j.eclinm.2024.102507_bib126","series-title":"Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults [NG215]","first-page":"1","year":"2022"},{"key":"10.1016\/j.eclinm.2024.102507_bib127","series-title":"For Kaiser Permanente. Benzodiazepine and Z-drug safety guideline","first-page":"1","author":"Sparks","year":"2022"},{"key":"10.1016\/j.eclinm.2024.102507_bib128","series-title":"Guidance on appropriate prescribing of benzodiazepines and Z-drugs (BZRA) for the treatment of anxiety and insomnia","first-page":"1","author":"Barry","year":"2021"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102507_bib129","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5770\/cgj.23.419","article-title":"Canadian guidelines on benzodiazepine receptor agonist use disorder among older adults title","volume":"23","author":"Conn","year":"2020","journal-title":"Can Geriatr J"},{"key":"10.1016\/j.eclinm.2024.102507_bib130","series-title":"Benzodiazepine taper guidelines for older adults in an inpatient geiatric\/psychiatric unit","first-page":"1","author":"Amanti","year":"2018"},{"key":"10.1016\/j.eclinm.2024.102507_bib131","series-title":"Guidelines for the use of benzodiazepines in the state of New Mexico","first-page":"1","year":"2018"},{"key":"10.1016\/j.eclinm.2024.102507_bib132","series-title":"Prescribing drugs of dependence in general practice, Part B\u2014benzodiazepines","first-page":"1","year":"2015"},{"key":"10.1016\/j.eclinm.2024.102507_bib133","series-title":"Guidance leaflet\u2013discontinuation of benzodiazepines and related medicinal products: procedure for the doctor providing outpatient treatment","first-page":"1","author":"Haute Autorite de Sante","year":"2015"},{"key":"10.1016\/j.eclinm.2024.102507_bib134","series-title":"Guidelines for prescribing and tapering benzodiazepines in an outpatient setting","first-page":"1","year":"2014"},{"key":"10.1016\/j.eclinm.2024.102507_bib135","series-title":"A\u00a0consensus statement on the use of benzodiazepines in specialist mental health services","first-page":"1","author":"College of Psychiatry of Ireland","year":"2012"},{"key":"10.1016\/j.eclinm.2024.102507_bib136","series-title":"For ministry of health Singapore. prescribing of benzodiazepines","first-page":"1","author":"Lee","year":"2008"},{"key":"10.1016\/j.eclinm.2024.102507_bib137","series-title":"For government of Ireland\u2013department of health and children. Benzodiazepines: good practice guidelines for clinicians","first-page":"1","author":"Crowley","year":"2002"},{"issue":"12","key":"10.1016\/j.eclinm.2024.102507_bib138","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1360-0443.1993.tb02046.x","article-title":"Guidelines for the prevention and treatment of benzodiazepine dependence: summary of a report from the Mental Health Foundation","volume":"88","author":"Lader","year":"1993","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102507_bib139","doi-asserted-by":"crossref","first-page":"366","DOI":"10.5498\/wjp.v5.i4.366","article-title":"Treating comorbid anxiety and depression: psychosocial and pharmacological approaches","volume":"5","author":"Coplan","year":"2015","journal-title":"World J Psychiatr"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102507_bib140","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000486696","article-title":"Benzodiazepines as a monotherapy in depressive disorders: a systematic review","volume":"87","author":"Benasi","year":"2018","journal-title":"Psychother Psychosom"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102507_bib141","doi-asserted-by":"crossref","DOI":"10.4088\/PCC.16r02037","article-title":"Prescribed benzodiazepines and suicide risk: a review of the literature","volume":"19","author":"Dodds","year":"2017","journal-title":"Prim Care Companion CNS Disord"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102507_bib142","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/YIC.0000000000000316","article-title":"Understanding the effects of chronic benzodiazepine use in depression: a focus on neuropharmacology","volume":"35","author":"Lim","year":"2020","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102507_bib143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-019-2312-3","article-title":"Association between benzodiazepines and suicide risk: a matched case-control study","volume":"19","author":"Cato","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.eclinm.2024.102507_bib144","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/acps.13582","article-title":"Risk of suicide attempt and suicide associated with benzodiazepine: a nationwide case crossover study","volume":"148","author":"Tournier","year":"2023","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102507_bib145","article-title":"Antidepressants plus benzodiazepines for adults with major depression","author":"Ogawa","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102507_bib146","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1586\/14737175.2014.963057","article-title":"The reappraisal of benzodiazepines in the treatment of anxiety and related disorders","volume":"14","author":"Starcevic","year":"2014","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102507_bib147","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1192\/bjp.2020.164","article-title":"Benzodiazepines: it's time to return to the evidence","volume":"218","author":"Silberman","year":"2021","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102507_bib148","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2125.2004.02089.x","article-title":"Alprazolam is relatively more toxic than other benzodiazepines in overdose","volume":"58","author":"Isbister","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102507_bib149","article-title":"Benzodiazepines versus placebo for panic disorder in adults","author":"Breilmann","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102507_bib150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01.paf.0000153994.95642.c1","article-title":"Alprazolam-related deaths in Palm Beach County","volume":"26","author":"Wolf","year":"2005","journal-title":"Am J Forensic Med Pathol"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102507_bib151","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/13607863.2015.1015961","article-title":"Systemic model of chronic benzodiazepine use among mature adults","volume":"20","author":"P\u00e9rodeau","year":"2016","journal-title":"Aging Ment Health"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102507_bib152","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/ADM.0000000000000350","article-title":"A\u00a0review of alprazolam use, misuse, and withdrawal","volume":"12","author":"Ait-Daoud","year":"2018","journal-title":"J\u00a0Addiction Med"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102507_bib153","first-page":"353","article-title":"Clonazepam for the treatment of panic disorder","volume":"14","author":"Nardi","year":"2013","journal-title":"Curr Drug Targets"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102507_bib154","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/02698811211069096","article-title":"Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: a population-based cohort study","volume":"36","author":"Davies","year":"2022","journal-title":"J\u00a0Psychopharmacol"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102507_bib155","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/PRA.0000000000000091","article-title":"Benzodiazepines for PTSD: a systematic review and meta-analysis","volume":"21","author":"Guina","year":"2015","journal-title":"J\u00a0Psychiatr Pract"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102507_bib156","first-page":"1","article-title":"An emulation of randomized trials of administrating benzodiazepines in PTSD patients for outcomes of suicide-related events","volume":"9","author":"Gilbert","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.eclinm.2024.102507_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114840","article-title":"An evidence-based approach to psychopharmacology for post-traumatic stress disorder (PTSD)\u20142022 update","volume":"317","author":"Bajor","year":"2022","journal-title":"Psychiatr Res"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102507_bib158","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/02698811221080464","article-title":"To BDZ or not to BDZ? That is the question! Is there reliable scientific evidence for or against using benzodiazepines in the aftermath of potentially traumatic events for the prevention of PTSD? A systematic review and meta-analysis","volume":"36","author":"Campos","year":"2022","journal-title":"J\u00a0Psychopharmacol"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102507_bib159","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2174\/1871527320666210618103344","article-title":"Benzodiazepines and sleep architecture: a systematic review","volume":"22","author":"de Mendon\u00e7a","year":"2023","journal-title":"CNS Neurol Disord\u2013Drug Targets"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102507_bib160","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.sleep.2013.03.012","article-title":"Sleep quality of benzodiazepine users in nursing homes: a comparative study with nonusers","volume":"14","author":"Bourgeois","year":"2013","journal-title":"Sleep Med"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102507_bib161","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/13607861003781833","article-title":"Benzodiazepine use and quality of sleep in the community-dwelling elderly population","volume":"14","author":"B\u00e9land","year":"2010","journal-title":"Aging Ment Health"},{"key":"10.1016\/j.eclinm.2024.102507_bib162","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2022.1029554","article-title":"Orexin dual receptor antagonists, zolpidem, zopiclone, eszopiclone, and cognitive research: a comprehensive dose-response meta-analysis","volume":"16","author":"Zhou","year":"2023","journal-title":"Front Hum Neurosci"},{"key":"10.1016\/j.eclinm.2024.102507_bib163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40360-015-0019-8","article-title":"Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review","volume":"16","author":"Pollmann","year":"2015","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.eclinm.2024.102507_bib164","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40266-018-0544-4","article-title":"Deprescribing benzodiazepines in older patients: impact of interventions targeting physicians, pharmacists, and patients","volume":"35","author":"Ng","year":"2018","journal-title":"Drugs Aging"},{"key":"10.1016\/j.eclinm.2024.102507_bib165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13012-022-01206-7","article-title":"Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework","volume":"17","author":"Evrard","year":"2022","journal-title":"Implement Sci"},{"key":"10.1016\/j.eclinm.2024.102507_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2019.101214","article-title":"Psychosocial intervention for discontinuing benzodiazepine hypnotics in patients with chronic insomnia: a systematic review and meta-analysis","volume":"48","author":"Takaesu","year":"2019","journal-title":"Sleep Med Rev"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102507_bib167","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/pcn.13195","article-title":"Does cognitive behavioral therapy for anxiety disorders assist the discontinuation of benzodiazepines among patients with anxiety disorders? A systematic review and meta-analysis","volume":"75","author":"Takeshima","year":"2021","journal-title":"Psychiatr Clin Neurosci"},{"key":"10.1016\/j.eclinm.2024.102507_bib168","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s40261-018-0648-y","article-title":"Translating benzodiazepine utilization data into meaningful population exposure: integration of two metrics for improved reporting","volume":"38","author":"Brandt","year":"2018","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.eclinm.2024.102507_bib169","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.drugalcdep.2018.04.028","article-title":"Adjunctive pharmacologic approaches for benzodiazepine tapers","volume":"189","author":"Welsh","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102507_bib170","article-title":"Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users","author":"Baandrup","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.eclinm.2024.102507_bib171","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1360-0443.1994.tb03755.x","article-title":"The treatment of benzodiazepine dependence","volume":"89","author":"Ashton","year":"1994","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102507_bib172","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S2215-0366(19)30032-X","article-title":"Tapering of SSRI treatment to mitigate withdrawal symptoms","volume":"6","author":"Horowitz","year":"2019","journal-title":"Lancet Psychiatr"},{"key":"10.1016\/j.eclinm.2024.102507_bib173","doi-asserted-by":"crossref","DOI":"10.1177\/20451253231171518","article-title":"Outcomes of hyperbolic tapering of antidepressants","volume":"13","author":"van Os","year":"2023","journal-title":"Ther Adv Psychopharmacol"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102507_bib174","first-page":"209","article-title":"Artificial intelligence and the conduct of literature reviews","volume":"37","author":"Wagner","year":"2022","journal-title":"J\u00a0Inf Technol"},{"key":"10.1016\/j.eclinm.2024.102507_bib175","series-title":"Benzodiazepines: how they work and how to withdraw","first-page":"1","author":"Ashton","year":"2002"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102507_bib176","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s41999-023-00777-y","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 3","volume":"14","author":"O'Mahony","year":"2023","journal-title":"Eur Geriatr Med"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102507_bib177","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","author":"2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2023","journal-title":"J\u00a0Am Geriatr Soc"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024000865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024000865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T02:35:36Z","timestamp":1751510136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537024000865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":177,"alternative-id":["S2589537024000865"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102507","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102507"}}